Sickle Cell Disease is a genetic blood disorder characterised by the presence of sickle-shaped red blood cells ...

In a new study, researchers found that the inflammation behind painful episodes in sickle cell disease are correlated with ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease ... that occur when red blood cells become misshapen and block blood vessels – per year.

HealthDay News — For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published ...